Summary

Report Scope
This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.
Report Includes
- An overview of the global markets for decentralized clinical trials (DCT)
- An analysis of the global market trends with market revenue data from 2022- 2025, and projected CAGRs through 2030
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by study design, therapeutic application, deployment mode, end user, and region
- Facts and figures pertaining to the market dynamics, technical advances, regulations, impact of macroeconomic factors, and R&D activities
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Company profiles

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Current Market Overview
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of the U.S. Tariffs
Porter's Five Forces Analysis
Potential for New Entrants: Moderate
Bargaining Power of Suppliers: Moderate
Bargaining Power of Buyers: Moderate to High
Threat of Substitute Products or Services: Low to Moderate
Industry Competition: High
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Demand for Improved Patient Access and Trial Diversity
Favorable Regulatory Support for Decentralized Clinical Trials
Technological Proliferation and Digital Infrastructure
Market Restraints
Data Integrity and Security Concerns
Operational and Logistical Complexities
Market Opportunities
Integration of Artificial Intelligence and Wearable Technologies
Extending Clinical Research Reach to Underserved and Remote Areas
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Next-Generation Digital Trial Platforms and Integrated Ecosystems
Wearables, Remote Monitoring and Digital Biomarkers
Automation, AI and Predictive Trial Management
Digital Patient and Investigator Workflow Optimization
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Study Design
Key Takeaways
Interventional Trials
Observational Trials
Expanded Access
Market Analysis by Therapeutic Application
Key Takeaways
Oncology
Cardiology
Others
Market Analysis by Deployment Mode
Key Takeaways
Cloud-Based DCT Platforms
On-Premises Solutions
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Collaborations
Chapter 8 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
CLARIO
FORTREA
ICON PLC
LABCORP
MEDABLE INC.
MEDIDATA
OBVIO HEALTH USA INC.
PAREXEL INTERNATIONAL (MA) CORP.
THERMO FISHER SCIENTIFIC INC.
VEEVA SYSTEMS INC.

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Decentralized Clinical Trials, by Region, Through 2030
Table 1 : Global Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 2 : Global Market for Interventional Decentralized Clinical Trials, by Region, Through 2030
Table 3 : Global Market for Observational Decentralized Clinical Trials, by Region, Through 2030
Table 4 : Global Market for Expanded Access Decentralized Clinical Trials, by Region, Through 2030
Table 5 : Global Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 6 : Global Market for Oncology in Decentralized Clinical Trials, by Region, Through 2030
Table 7 : Global Market for Cardiology in Decentralized Clinical Trials, by Region, Through 2030
Table 8 : Global Market for Other Therapeutic Applications in Decentralized Clinical Trials, by Region, Through 2030
Table 9 : Global Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 10 : Global Market for Cloud-Based DCT Platforms in Decentralized Clinical Trials, by Region, Through 2030
Table 11 : Global Market for On-Premises Solutions in Decentralized Clinical Trials, by Region, Through 2030
Table 12 : Global Market for Decentralized Clinical Trials, by End User, Through 2030
Table 13 : Global Market for Pharmaceutical and Biotechnology Companies in Decentralized Clinical Trials, by Region, Through 2030
Table 14 : Global Market for CROs in Decentralized Clinical Trials, by Region, Through 2030
Table 15 : Global Market for Other End Users in Decentralized Clinical Trials, by Region, Through 2030
Table 16 : Global Market for Decentralized Clinical Trials, by Region, Through 2030
Table 17 : North American Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 18 : North American Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 19 : North American Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 20 : North American Market for Decentralized Clinical Trials, by End User, Through 2030
Table 21 : European Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 22 : European Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 23 : European Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 24 : European Market for Decentralized Clinical Trials, by End User, Through 2030
Table 25 : Asia-Pacific Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 26 : Asia-Pacific Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 27 : Asia-Pacific Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 28 : Asia-Pacific Market for Decentralized Clinical Trials, by End User, Through 2030
Table 29 : RoW Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 30 : RoW Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 31 : RoW Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 32 : RoW Market for Decentralized Clinical Trials, by End User, Through 2030
Table 33 : Global Ranking of Companies in the Market for Decentralized Clinical Trials, 2024
Table 34 : Mergers and Acquisitions in the Decentralized Clinical Trials Industry, 2025
Table 35 : Collaborations in the Decentralized Clinical Trials Industry, 2023–2025
Table 36 : Information Sources Used for this Report
Table 37 : Abbreviations Used in this Report
Table 38 : Clario: Company Snapshot
Table 39 : Clario: Product Portfolio
Table 40 : Clario: News/Key Developments, 2023–2025
Table 41 : Fortrea: Company Snapshot
Table 42 : Fortrea: Financial Performance, FY 2023 and 2024
Table 43 : Fortrea: Product Portfolio
Table 44 : Fortrea: News/Key Developments, 2023–2025
Table 45 : ICON plc: Company Snapshot
Table 46 : ICON plc: Financial Performance, FY 2023 and 2024
Table 47 : ICON plc: Product Portfolio
Table 48 : ICON plc: News/Key Developments, 2023–2025
Table 49 : Labcorp: Company Snapshot
Table 50 : Labcorp: Financial Performance, FY 2023 and 2024
Table 51 : Labcorp: Product Portfolio
Table 52 : Labcorp: News/Key Developments, 2022–2025
Table 53 : Medable Inc.: Company Snapshot
Table 54 : Medable Inc.: Product Portfolio
Table 55 : Medable Inc.: News/Key Developments, 2023–2025
Table 56 : Medidata: Company Snapshot
Table 57 : Medidata: Product Portfolio
Table 58 : Medidata: News/Key Developments, 2023–2025
Table 59 : Obvio Health USA Inc.: Company Snapshot
Table 60 : Obvio Health USA Inc.: Product Portfolio
Table 61 : Obvio Health USA Inc.: News/Key Developments, 2023–2025
Table 62 : Parexel International (MA) Corp.: Company Snapshot
Table 63 : Parexel International (MA) Corp.: Product Portfolio
Table 64 : Parexel International (MA) Corp.: News/Key Developments, 2024–2025
Table 65 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 66 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 67 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 68 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023–2025
Table 69 : Veeva Systems Inc.: Company Snapshot
Table 70 : Veeva Systems Inc.: Financial Performance, FY 2023 and 2024
Table 71 : Veeva Systems Inc.: Product Portfolio
Table 72 : Veeva Systems Inc.: News/Key Developments, 2025